Clinical trial
Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and…
NCT00159380 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00159380 |
|---|---|
| Title | Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects |
| Official title | A Double Blind, Crossover Placebo-controlled Study to Evaluate the Effect of L-arginine and Aminoguanidine on Bronchial, Alveolar and Nasal NO and NO Metabolites |
| Lead sponsor | Imperial College London, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Aminoguanidine, Placebos |
| Enrollment | 16 |
| Start date | Sep 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 10, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: